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Abstracts / International Journal of Surgery 12 (2014) S13eS117S16Methods: Clinical data and MMP-3 levels were recorded prospectively for
278 RA patients over a 5-year period. The mean (sd) age of the cohort was
59 (9.9) years with a disease duration of 11(9.2) years and 187 (67%) of the
cohort were female.
Results: Signiﬁcantly higher levels of MMP-3 were found at baseline for
those patients who required a joint replacement during the ﬁve year
follow up period (n¼49) than those that did not: median (IQR) MMP-3
level (27,050 (37,146) vs. 19,892 (18,894), p ¼0.005). No signiﬁcant differ-
ence was found between baseline MMP-3 levels and having a joint
replacement prior to the start of the study (n¼32): median (IQR) MMP-3
level (25,705 (21,283) vs. 20,031 (20,258), p ¼0.25).
Conclusions: High levels of MMP-3 are associated with future joint
replacement of the hip or knee in RA patients.
1275: THE EFFECTS OF SOCS7 KNOCKDOWN IN BREAST CANCER CELLS:
THEIR IN VITRO RESPONSE TO HEPATOCYTE GROWTH FACTOR (HGF)
Walid Sasi 1,*, Lin Ye 2, Wen G. Jiang 2, Anup K. Sharma 1, Kefah Mokbel 1.
1 St George's, University of London, London, UK; 2 Cardiff University, Cardiff,
UK.
Introduction: Phospholipase Cg-1 (PLCg-1) is an important Hepatocyte
Growth Factor (HGF) receptor (C-MET) downstream mediator, and recent
evidence showed that Suppressor of Cytokine Signalling 7(SOCS7) - a
member of the SOCS family - interacts with PLCg-1. Here, we aimed to
investigate SOCS7 knockdown effect on breast cancer cellular growth and
migratory responses to HGF treatment, and whether this involves HGF-
PLCg-1 pathway using the PLCg-1 blocker U73122.
Methods: Two breast cancer cell lines (MCF7 and MDA-MB-231) were
transfected with anti-SOCS7 ribozymal transgene, creating sublines
with SOCS7 knockdown (MCF7DSOCS7 and MDA-MB-231DSOCS7), veriﬁed
by RT-PCR. The growth and migration of the cells were evaluated with
and without HGF and U73122 pre-treatment using growth assay,
scratch-wound and Electrical Cell Impedance Sensing (ECIS) migration
assays.
Results: Under basic conditions, both MCF7DSOCS7 and MDA-MB-231DSOCS7
cells showed higher growth and migration compared to control cells.
Additionally SOCS7 knockdown appeared to synergistically enhance their
growth and migratory responses to HGF. U73122 pre-treatment was found
to abrogate this synergistic effect.
Conclusions: HGF pre-treatment and SOCS7 knockdown have a syner-
gistic effect on the growth and migration of MCF7 and MDA-MB-231 cells.
This is lost with pre-treatment with U73122, an alternative PLCg-1 blocker,
indicating a precise anti-PLCg-1 regulatory role for SOCS7.
Breast surgery
0008: USE OF AUTOLOGOUS FAT GRAFTING FOR RECONSTRUCTION
POST-MASTECTOMY AND BREAST CONSERVING SURGERY: A SYSTEM-
ATIC REVIEW AND META-ANALYSIS
Riaz Agha*,1, Alexander Fowler 2, Christian Herlin 3, Tim Goodacre 4,
Dennis Orgill 5. 1Department of Plastic Surgery, Stoke Mandeville Hospital,
UK; 2Barts and the London School of Medicine and Dentistry, QMUL, London,
UK; 3CC-AH en chirurgie plastique, reconstructrice et esthetique, Montpellier,
France; 4Department of Plastic Surgery, John Radcliffe Hospital, Oxford, UK;
5Division of Plastic Surgery, Brigham and Women’s Hospital, Boston,
Massachusetts, USA.
Introduction: There is growing interest in the potential of autologous
fat grafting (AFG) for breast reconstruction. However, concerns
remains regarding its effectiveness, safety and interference with
mammography.
Methods: A protocol was published a priori. All studies investigating AFG
for women undergoing reconstruction post surgery for treatment of breast
cancer were considered. We assessed six domains; Oncological, clinical,
aesthetic/functional, patient reported, process and radiological. Electronic
databases and grey literature sources were searched to June 2013.
Results: 31 studies were included in this review (3,521 patients). Fat ne-
crosis is the commonest reported complication at 4.4% (the majority was
managed conservatively). Other harms include the anxiety caused by the
need for further radiological investigation through interval mammograms
(11.5%) and the need for biopsy (2.5%) to exclude malignancy. Theweighted mean recurrence rate was 4.4% at a median of 18.3 months.
Random effects Meta-analysis showed no signiﬁcant difference (p¼0.10).
We were unable to comment from the data on whether AFG is more
successful in combination with other techniques or alone.
Conclusions: The need for long-term follow up is underscored by this
review. High quality research is required to demonstrate long-term
oncological ramiﬁcations and to determine the potential for AFG as a total
breast reconstruction.
0244: AN EVALUATION OF THE CORRELATION BETWEEN PRIMARY
TUMOUR AND LYMPH NODE RESPONSE FOLLOWING NEOADJUVANT
THERAPY IN BREAST CANCER
C.A. Fleming*, K.N. McCarthy, M.J. O'Sullivan, H.P. Redmond, M.A. Corrigan.
Breast Research Centre, Cork University Hospital, Cork, Ireland.
Introduction: Neoadjuvant therapy (NAT) offers an opportunity to
assess tumour response to systemic agents. However discrepancy may
exist between response of primary tumour & involved nodes. This
study sought to assess the frequency of discordance in this response post
NAT.
Methods: All node positive patients receiving NAT at Cork University
Hospital, Republic of Ireland from 2009-2012 were identiﬁed. Basic
demographics, radiological & pathological features were tabulated &
analysed. Nodal response was estimated from standard pathological
response to treatment measurements. Statistical analysis was performed.
Results: 66 node positive patients had completed surgery & were eligible
for inclusion. Median age was 50 years, all patients underwent axillary
clearance and 64% underwent mastectomy. There was an overall positive
correlation between tumour and lymph node (LN) response following NAT
(Spearman correlation coefﬁcient 0.541, p<0.001). Eleven patients ach-
ieved a LN complete pathological response (CPR) with all having a CPR in
tumour also. A CPR in the tumour predicted complete nodal response in
73% of cases.
Conclusions:While overall correlation was seen, 27% of primary tumours
with CPR had persistently positive LN's. This represents a signiﬁcant
discordance that may be due to biomolecular differences and represents a
concern for the potential lack of response of occult systemic metastasis to
NAT.
0333: BREAST CANCER, WHAT WOULD YOU CHOOSE? e A SURVEY OF
HEALTH PROFESSIONALS
Emma Woolley*,1, Mohammed Elsayed 1, Michael Carr 2,
Ludger Barthelmes 1. 1North Cumbria University Hospitals Trust, Cumbria,
UK; 2Northumbria NHS Trust, Northumbria, UK.
Introduction: To investigate whether medical professionals, when con-
fronted with a breast cancer diagnosis, would ignore evidence-based
medicine in favour of personal preference. Compare the opinion of the
breast team with the actual treatment chosen by their patients.
Methods: Anonymous questionnaire with 3 scenarios given to all (39)
members of the regional MDT and comparison made with patients'
treatment choices.
Results: For a 10 mm, grade 1 cancer 82 % (32/39) of health professionals
favoured WLE over mastectomy, compared to 51 % (31/60) of patients
(p¼0.003). For a 25mm, grade II, invasive cancer 55% (21/38) of medical
professionals favoured WLE compared to 49% (28/57) of patients
(p¼0.67). For 60mm, high grade DCIS, 26% (10/39) of health professionals
would chose mastectomy without reconstruction, compared to 75 % (9/
12) of patients (p¼0.005). Following a mastectomy, 74 % of health pro-
fessionals would have reconstruction: 28 % immediately, 46 % delayed;
whilst of the 25 % of patients with reconstructions all had immediate
reconstruction.
Conclusions: A signiﬁcant majority of health professionals would
choose WLE for grade I and II invasive ductal carcinoma compared to
their patients' treatment choices. For 60mm DCIS, health professionals
were more three times more likely than their patients to choose re-
construction.
0388: THE UTILISATION OF MAGNETIC RESONANCE IMAGING IN THE
INVESTIGATION OF INVASIVE LOBULAR CARCINOMA e A RETROSPEC-
TIVE STUDY IN TWO DISTRICT GENERAL HOSPITALS
Mina Derias*, Ashok Subramanian, Simon Allan, Elizabeth Shah,
Hassan El-Teraiﬁ, David Howlett. East Sussex Healthcare, Eastbourne, UK.
Abstracts / International Journal of Surgery 12 (2014) S13eS117 S17Introduction: Invasive lobular carcinoma (ILC) accounts for 10% of breast
cancers and is associated with multifocal and contralateral breast
involvement. The National Institute of Clinical Excellence (NICE) guidelines
(2009) recommended the use of Magnetic Resonance Imaging (MRI) in the
preoperative assessment of ILC. This study aims to assess compliance with
guidelines in two District General Hospitals and the utility of MRI in the
investigation of ILC.
Methods: All cases of ILC between 2011 and 2013 were retrospectively
identiﬁed from the pathology database and their breast imaging ﬁndings
were reviewed.
Results: 107 patients had ILC, of these 41 hadMRI preoperatively (38%). MRI
upgraded mammography/ultrasound diagnoses in 8 patients (19.5%). MRI
showed multifocal disease in 13 patients (31.7%) occult on ultrasound/
mammogram, with these patients undergoing mastectomy. MRI showed a
contralateral lesion in 9 patients, 4 (9.8%) of which were ILC (5 benign) with
these patients having bilateral surgery. MRI also downgraded 4 (9.8%) pa-
tients to unifocal disease with reported multifocal appearances on
mammography/ultrasound, andMRI ﬁndings were conﬁrmed histologically.
Conclusions:MRI is highly accurate in the diagnosis of bothmultifocal and
contralateral disease in ILC and should be undertaken in all such cases
preoperatively assuming no contraindication.
0530: RATE OF RE-INTERVENTION FOLLOWING BREAST CANCER TREAT-
MENT WITH THERAPEUTIC ROUND BLOCK MAMMOPLASTY: 7 YEARS
SINGLE CENTRE EXPERIENCE
Jason On*, Elaine Yeap, Shailesh Chaturvedi. Aberdeen Royal Inﬁrmary,
Aberdeen, UK.
Introduction: Wide local excision has been the procedure of choice for
breast-conserving surgery in patients with breast cancer. This can
sometimes result in less than an ideal cosmetic outcome for the patient
such as loss of volume in the breast. Therapeutic round block mammo-
plasty (RBM) is a technique that can be used to improve these cosmetic
outcomes. The aim of this study is to look at the need for re-intervention
following RBM.
Methods: Tumour size, grade and other patient factors were collected in
conjunction with the outcome following RBM from the period between
September 2006 and October 2013.
Results: 54 eligible patients were included in this study.10 patients (18.5%)
had pathology results of at least a single margin involvement or a margin
clearance of <1mm. 9 patients had invasive ductal carcinoma and 1 with
invasive lobular carcinoma, all of grades 2 and 3. The average tumour size
is 30.1mm. 6 patients subsequently had a second procedure, 3 each had
mastectomy and re-excision of margins. Therefore, the overall risk of re-
intervention is approximately 11% following RBM.
Conclusion: Round block mammoplasty should be considered as an
alternative for patients suitable for breast-conserving surgery as it has an
acceptable rate of re-intervention.
0652: VENOUS THROMBOEMBOLISM PROPHYLAXIS IN BREAST SUR-
GERY e WHAT ARE WE DOING?
Jake Sloane*, Sophie Helme, Jennifer Hu. St Bartholomew's Hospital, London,
UK.
Introduction: In breast surgery there is a balance of risk between venous
thromboembolism (VTE) and post-operative haematoma. The NICE
guidelines (2010) state that all cancer surgery patients should be given
mechanical and pharmacological prophylaxis unless contraindicated. In
the absence of national guidelines speciﬁc to Breast surgery we sought to
ascertain what current practice is within the UK.
Methods: Aweb-based survey was sent to surgeons within the 199 Breast
Units in the UK.
Results: Responses were received from 67 units. 33% give LMWH to day-
case patients and 72% to overnight patients. 27% use LMWH for high-risk
patients only. Pre-operative LMWH is given routinely in 11% and in high-
risk patients, 33%. Only 3% give LMWH post discharge. Surgery type in-
ﬂuences whether patients receive LMWH - over 90% for complex recon-
structive cases and 50% for wide local excisions. 67% of units use Local
Trust Guidelines for General or Breast Surgery, 33% are guided by indi-
vidual surgeon preference.
Conclusion: There is a wide variation in VTE prophylaxis within breast
units. In over 1/3 of units, there are no local or national protocols followed.We suggest a need for national guidelines speciﬁc to Breast Surgery to help
guide best practice.
0661: RESECTION MARGINS IN BREAST CONSERVING SURGERY. LESS IS
MORE
Andrew McDougall*, Ahmed Hamad. Mid Cheshire Hospitals NHS
Foundation Trust, Crewe, Cheshire, UK.
Introduction: Re-excision is performed in patients with early stage breast
cancer associated with close resection margins. Re-excision of margins in
breast-conserving surgery (BCS) imposes psychological, cosmetic and
economic burdens and may delay adjuvant therapy. There is lack of
consensus regarding what is to be considered adequate margins. The aim
of this study is to critically appraise current evidence on management of
close margins after BCS.
Methods: A literature review was done using PubMed and Google Scholar
search engines using key words and phrases including: “breast”, “cancer”,
“invasive”, “wide local excision” and “margins”. Papers published since the
year 2000 were considered.
Results: Forty-seven publications were identiﬁed. Substantial variations
exist in practice. The margin of normal tissue that signiﬁcantly reduces the
risk of local recurrence remains undeﬁned. Tumour biology plays a more
signiﬁcant role. With adjuvant therapy, close margins were not associated
with an increased risk of local recurrence compared to wider margins.
Conclusions: Decisions regarding resection margins in BCS should be
made in the context of tumour biology, adjuvant treatment and cosmetic
outcomes. With adjuvant therapy, wider margins do not reduce local
recurrence compared to close margins. Additional studies and a consensus
on management of surgical margins are needed.
0755: AXILLARY ULTRASOUND IN BREAST CANCER e A DGH EXPERI-
ENCE
Abraham Joel*, Shantanu Rout, Neal Ormsby, Huw Garrod, Avier Chong,
Shabbir Poonawala. Arrowe Park Hospital, Wirral, UK.
Introduction: Prognosis in breast cancer is primarily determined by
staging the axilla most commonly by sentinel lymph node biopsy (SLNB).
We aimed to look at our practice in theWirral breast unit and compare it to
national standards.
Methods: Retrospective analysis of all patients undergoing axillary ultra-
sound (US) at the Wirral breast unit over a 1 year period was undertaken.
Data was collected from the radiology database and patient records.
Results: 371 patients with breast cancer underwent axillary US that was
graded from A1 (normal) to A5 (likely malignant nodes). Of the 203 axillae
that were initially coded normal, 13.7% went on to have axillary node
clearance (ANC) and half had histological evidence of axillary nodal spread.
In 42 patients the axillawas coded A3 of which 26.1% needed clearance and
19% had histological evidence of disease. In A4 axillae 30% underwent ANC
of which 21.7% were positive and in A5 axillae 47.7% needed ANC of which
41% had disease.
Conclusions:AxillaryUS is themost appropriate initial test for assessing the
axilla. Pick up rates in our unit compare favourablywith national standards.
However there still remains a signiﬁcantly high false positive rate.
0800: DOES THE IMPLEMENTATION OF AN ENHANCED RECOVERY PRO-
GRAMME IMPACT ON POST-OPERATIVE OUTCOMES IN POPULATIONS
WITH SIGNIFICANT COMORBIDITY AND SOCIAL DEPRIVATION?
Ee Von Woon*, Pang Long Wong, Juliette Murray. Wishaw General Hospital,
Lanarkshire, UK.
Introduction: In Lanarkshire (Scotland), the Enhanced Recovery Pro-
gramme (ERP) was introduced inWishawGeneral Hospital in 2012 but has
yet to be extended to neighbouring Monklands Hospital. We audited the
impact of the ERP between these district general hospitals, which are both
in areas of signiﬁcant social deprivation.
Methods: All patients who underwent breast surgery from August 2012 to
August 2013 inclusive were identiﬁed from a prospectively collected
electronic database. Parameters analysed included length of postoperative
stay, rate of post-operative complications and re-admissions. The relative
social deprivation of patients was calculated with the Scottish Index of
Multiple Deprivation 2012.
Results: 294 and 152 patients underwent 336 and 161 breast operations in
Wishaw and Monklands respectively. The mean postoperative stay and
